Dronabinol is pure Tetrahydrocannabinol (THC) and is registered as an active pharmaceutical ingredient (API) and has been registered for sale with the appropriate authorities in
AMP and Eurox entered into a non-exclusive marketing and distribution agreement for Dronabinol for sale in pharmacies beginning in
Eurox was one of the first medical cannabis companies to produce Dronabinol made in
Dr.
About Eurox Pharma
Eurox Pharma is one of
- Fully owned German subsidiaries responsible for product development & holding IP.
- EU GMP manufacturing in
Germany together with a German pharmaceutical partner. - A cultivation facility in
Portugal to secure vertical integration and supply independence. - A significant minority ownership of
Integro Medical Clinics , aUK registered medical cannabis clinic. - Various high caliber distribution partnerships in
Germany and other European countries & its own sales team.
For more information on Eurox, please visit www.eurox-pharma.com
About
Greenrise Global helps people realize the beneficial properties of cannabis. Greenrise Global is a Canadian publicly traded corporation with two German operating subsidiaries:
AMP is based in Erfurt and supplies medical cannabis products to pharmacies across
For more information about Greenrise Global, please visit https://greenriseglobal.com/
FOLLOW US ON:
Twitter: https://twitter.com/GreenriseGlobal
LinkedIn: https://linkedin.com/company/greenriseglobal/
Instagram: https://www.instagram.com/greenriseglobal/
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accept responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking statements that are based on the Company's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to its business plans and milestones and the timing thereof. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements do not guarantee future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.
SOURCE
© Canada Newswire, source